UbeUBEOF 56 Receivables Turnover is 1.30 as of Mar. 2026. GuruFocus rates UBEOF with a GF Score™ of 56/100 and a GF Value™ of $11.05. The stock has 10 warning signs investors should review. Among 1,575 Chemicals companies, Ube ranks worse than 65.4% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Ube's Revenue for the
three
months ended in Mar. 2026 was $820 Mil. Ube's average Accounts Receivable for the
three
months ended in Mar. 2026 was $633 Mil.
Hence, Ube's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.30.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Ube Receivables Turnover Related Terms
Ube Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Ube's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UBEOF vs LIN, SHW, ECL: Receivables Turnover Comparison
For the Specialty Chemicals subindustry, Ube's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ube Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Ube's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Ube's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ube (UBEOF) has a Receivables Turnover of 1.30 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Ube and its competitors. According to the industry distribution chart, Ube ranks #1030 out of 1575 companies in the Chemicals industry, placing it in the top 65.4%.
Is Ube's Receivables Turnover too high?
Ube's current Receivables Turnover is 1.30. The Chemicals industry median Receivables Turnover is 5.56. Ube's value of 1.30 is 76.6% below this industry median. Based on the distribution chart, Ube ranks #1030 out of 1575 companies in the Chemicals industry, which is below the industry midpoint. Overall, Ube has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Ube's Receivables Turnover compare to LIN and SHW?
According to the Chemicals industry distribution chart, Ube ranks #1030 out of 1575 companies for Receivables Turnover. This places Ube in the lower half of its industry. The industry median Receivables Turnover is 5.56. Ube's value of 1.30 is 76.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.56, based on 1,575 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ube's current Receivables Turnover of 1.30 is 76.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Ube and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ube's current Receivables Turnover is 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ube stock overvalued right now?
Ube (UBEOF) has a current Receivables Turnover of 1.30. The stock's GF Value™ is $11.05, compared to a current price of $15.29 — trading 38.3% above its estimated fair value. The current Receivables Turnover is 1.30 and 76.6% below the Chemicals industry median of 5.56. Ube's overall GF Score™ is 56/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Ube (UBEOF), the current Receivables Turnover is 1.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ube (UBEOF) Overvalued in 2026?
Based on GuruFocus' analysis, Ube stock appears to be overvalued.
The current stock price of $15.29 is trading 38.3% above its estimated GF Value™ of $11.05.
Key valuation signals for UBEOF:
Receivables Turnover: 1.30
GF Value™: $11.05 vs. price of $15.29 (38.3% above fair value)
Industry Position: 76.6% below the Chemicals median (#1030 of 1575)
No single metric tells the full story. See the UBEOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ube Corp manufactures and sells chemicals, construction materials, and machinery products. The firm organizes itself into five segments based on product type. The chemicals segment, which generates more revenue than any other segment, sells a variety of chemicals including resins, rubber, silicon, and plastics. The cement and construction segment sells cement, plaster, and foundation materials to the construction and building industries. The pharmaceutical segment sells anti-allergic, anti-hypertensive, and anti-platelet drugs. The machinery and metal products segment sells die-casting and electric injection machines. The energy and environment segment generates electricity from coal and biomass. The majority of revenue comes from Japan.
56GF Score
Get the complete analysis for UBEOF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UBEOF has been successfully added to your 
